13471-69-7Relevant articles and documents
Novel anthracycline-spacer-β-glucuronide, -β-glucoside, and -β-galactoside prodrugs for application in selective chemotherapy
Leenders, Ruben G. G.,Damen, Eric W. P.,Bijsterveld, Edward J. A.,Scheeren, Hans W.,Houba, Pieter H. J.,Van Der Meulen-Muileman, Ida H.,Boven, Epie,Haisma, Hidde J.
, p. 1597 - 1610 (2007/10/03)
A series of anthracycline prodrugs containing an immolative spacer was synthesized for application in selective chemotherapy. The prodrugs having the general structure anthracycline-spacer-β-glycoside were designed to be activated by β-glucuronidase or β-galactosidase. Prodrugs with -chloro, -bromo or -n-hexyl substituents on the spacer were synthesized as well as prodrugs containing a -β-glucuronyl, -β-glucosyl or -β-galactosyl carbamate specifier. The key step in the synthesis of all prodrugs is the highly β-diastereoselective addition reaction of the anomeric hydroxyl of a glycosyl donor to a spacer isocyanate resulting in the respective β-glycosyl carbamate pro-moieties. The resulting protected pro-moieties were coupled to an anthracycline. Prodrugs were evaluated with respect to activation rate by the appropriate enzyme and additionally, their IC50 values were determined. Optimal prodrugs in this study were at least 100- to 200-fold less toxic than their corresponding drug in vitro and were activated to the parent drug in a half-life time of approximately 2h. Copyright (C) 1999 Elsevier Science Ltd.
THE PROMOTING EFFECT OF IRON COMPOUNDS IN THE SYNTHESIS OF ISOCYANATES BY THE CARBONYLATION OF NITROCOMPOUNDS
Niyazov, A. N.,Nefedov, B. K.,Khoshdurdyev, Kh. O.,Manov-Yuvenskii, V. I.
, p. 267 - 270 (2007/10/02)
-
